Minerva Capital Research Solutions

Artemis Medicare Services

NSE: ARTEMISMEDBSE: 542919
Compare with peers
₹ 299.00▼ 1.95 (−0.65%)28 Oct, 03:29 pm IST
Market cap
₹ 4,421 Cr.
P/E
40.8x
P/B
5.03x
52-week range
203.35 – 378.8
ROE
12%
ROCE
15%
Dividend yield
0.2%
Debt / equity
0.28
Sector
Healthcare Services
Industry
Hospital
Listed on
NSE, BSE

About

Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Hospital: 41 companies →

Artemis Medicare Services against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)40.8 against a typical 48.9: cheaper than most peers (1st = cheapest).15th of 40
  • Sales growth+12.8% against a typical +21.1% from a year earlier.26th of 34
  • Profit growth+47.6% against a typical +13% from a year earlier.6th of 31
  • Share price, 3 months+0.1% against a typical −10.9%.10th of 34
  • Size₹ 4,420.8 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).14th of 36

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Adequate safety

Rated A by CARE
A
DefaultRiskyModerateSafeVery safe
  • No warnings from the agency.
AgencyCurrent ratingOutlookAs of
CARECARE A / CARE A2+Stable30 Sep 2026
Credit rating actions
RatingDetails
30 Sep 2026
Reaffirmed
CARE A → CARE A / CARE A2+—CARE₹ 388.15 Cr.
12 Aug 2025
Reaffirmed
CARE A—CARE₹ 472.9 Cr.

Board meetings

Results dates and other board meetings. Full calendar

Details
30 Oct 2026UpcomingFinancial ResultsTo consider and approve the financial results for the period ended September 30, 2026
3 Aug 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
4 Jun 2026Other business mattersTo consider and approve the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds
8 May 2026Financial ResultsTo consider and approve Audited Financial Results and recommendation of dividend, If any.
2 Feb 2026Financial Results/Fund RaisingTo consider and approve (i) the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31, 2025; and (ii) the proposal for raising of funds by way of issuance of any instrument or security including equity shares, fully or partly convertible debentures, non-convertible debentures along with warrants, in one or more tranches, including by way of preferential allotment or a private placement (including one or more Qualified Institutions Placements).
11 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
5 Aug 2025Financial ResultsTo consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2025.

Share price

1Y change +20.76%
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales217210217217235227235250270267274282
Expenses184179181181193190199209220223224227
Operating Profit333236364237364150445055
OPM %15%15%17%16%18%16%15%16%19%16%18%20%
Other Income2224891278485
Interest788888877766
Depreciation91010101111111111121212
Profit before tax191619223127293040303942
Tax %27%29%28%24%27%23%20%29%25%24%25%26%
Net Profit141214172321232130233031
EPS in Rs1.010.851.021.241.641.511.691.542.161.421.871.96

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
10%
5 Years
21%
3 Years
14%
TTM
15%
Compounded Profit Growth
10 Years
17%
5 Years
76%
3 Years
40%
TTM
31%
Stock Price CAGR
10 Years
—
5 Years
57%
3 Years
38%
TTM
—
Return on Equity
10 Years
10%
5 Years
12%
3 Years
12%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
58.39%
−8.14 pts in a year
FIIs
12.28%
+12.04 pts in a year
DIIs
2.4%
−2.36 pts in a year
Government
6.16%
−0.86 pts in a year
Public
20.76%
−0.69 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 40.8xEPS (12 months) ₹ 7.59Median P/E 39.3x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Artemis Medicare Services₹ 299.00₹ 4,421 Cr.40.8x5x12%—
Apollo Hospitals Enterprise₹ 7,731.95₹ 1,11,174 Cr.64.9x13.4x22%7.8%
Max Healthcare Institute₹ 817.00₹ 79,519 Cr.71.5x9.9x14.3%17.2%
Fortis Healthcare₹ 720.00₹ 54,357 Cr.67.9x7.3x11.1%11.7%
Aster DM Healthcare₹ 651.00₹ 56,817 Cr.102.6x9.3x9.7%9.2%
Narayana Hrudayalaya₹ 1,667.25₹ 33,862 Cr.48.1x9.1x19.9%10.3%

Management

Sanjiv Kumar Kothari
Chief Financial Officer
Poonam Makkar
Compliance Officer, Company Secretary
Devlina Chakravarty
Managing Director, Executive Director

Prices are delayed and for information only. Nothing on this page is investment advice.